Drug News Weekly (E-Mail Newsletter)
To renew your subscription to Drug News Weekly (E-Mail Newsletter), please click
on the link above or call 800.223.0554, Press 2.
Drug News Weekly delivers the latest drug information and news via e-mail.
Weekly updates provide critical information such as new drug approvals, new indications,
new warnings, new doseforms, withdrawals, Rx-to-OTC status switches, patient safety
information, and much more. Also included are summaries of notable medical journal
articles and information about drug news in the popular press to address any patient
questions and concerns. Stay up-to-date on the latest drug news with
Drug News Weekly.
To read a sample issue of Drug News Weekly
Click Here
.
You will need
Adobe Reader®
to view the document.
INCLUDES
- New FDA approvals
- New indications, interactions, and warnings
-
Extra
issues covering urgent information
Product Code: 1532-3854